Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Neoplasms 3Anxiety Disorders 3Pain 2Gastrointestinal Neoplasms 2Depression 2Acute Pain 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Otolaryngeal Cancer 1Mucositis 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1Agnosia 1

Interventions

Ketamine 2Surveys and Questionnaires 1Psychotherapy 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Acute Pain × Ketamine × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

NCT03959852 2020-09-11

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Mercy Health Ohio

Phase 4 Terminated
6 enrolled
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡